LINCOLN, Neb. Drugmaker seeks to block Nebraska from using execution drugs

STL.News



LINCOLN, Neb. — A German pharmaceutical company has filed a lawsuit to prevent Nebraska from using lethal injection drugs next week in what would be the state’s first execution in more than two decades.

The federal lawsuit filed late Tuesday could delay the Aug. 14 execution of Carey Dean Moore, who was sentenced to death for killing two Omaha cab drivers in 1979. The company, Fresenius Kabi, opposes the use of its drugs in executions and alleges that the Nebraska Department of Correctional Services’ supply of potassium chloride was made by the company.

Continue reading LINCOLN, Neb. Drugmaker seeks to block Nebraska from using execution drugs at STL.News.



Source link